EXAS - Company ID 0001124140
The table below shows EXACT SCIENCES CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $30.81M | -$82.31M | -$38.22M | -$173.75M | -$77.23M | -$49.83M |
| Capital expenditure | $31.17M | $37.65M | $29.36M | $33.62M | $12.92M | $13.05M |
| Investing cash flow | -$34.44M | -$171.44M | $82.94M | $45.56M | -$317.51M | -$405.85M |
| Dividends paid | - | - | - |
EXACT SCIENCES CORP reported operating cash flow of $491.44M for fiscal year 2025. That is up 133.4% from $210.54M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$130.07M (FY 2016) to $491.44M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$256.17M | -$3.00M | $133.60M | $2.73M | $7.25M | $979.48M |